Bullseye Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bullseye Investment Management's LLY Position: Q2 2026 in Review
Bullseye Investment Management reduced its Eli Lilly (LLY) stake by 18% in Q2 2026, selling an estimated $483K and leaving 2,107 shares worth $2.53M. The position accounts for 1.24% of the portfolio, ranked #18.
Bullseye Investment Management first reported a position in LLY in Q4 2022 and has held it in 7 quarters since. The position peaked at $2.82M in Q4 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bullseye Investment Management held 2,107 shares of Eli Lilly worth $2.53M as of Q2 2026.
- Bullseye Investment Management sold 473 Eli Lilly shares in Q2 2026, an estimated $483K.
- Eli Lilly made up 1.24% of Bullseye Investment Management's portfolio in Q2 2026, its #18 holding.
- Bullseye Investment Management first reported a position in Eli Lilly in Q4 2022 and has held it in 7 quarters since.
- Bullseye Investment Management's Eli Lilly position peaked at $2.82M in Q4 2025.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bullseye Investment Management's 13F filing for Q2 2026, filed 11 Sep 2026.